Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer. (Q44806064)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Hans Vasen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Remi A Nout

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Carien L Creutzberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Natalja T ter Haar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Laura M Seeber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Paul J v Diest

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Frederik J Hes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Hans Morreau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Vincent T H B M Smit

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

24 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

1525-1535

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23702729%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.96

1 March 2020

exact match

0 references

cites work

Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

The SWI/SNF complex and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

SWI/SNF nucleosome remodellers and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

ARID1A mutations in cancer: another epigenetic tumor suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

A proposed model for endometrial serous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

INI1-deficient tumors: diagnostic features and molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Targeting the mTOR/4E-BP pathway in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

DNA methylation in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

7 January 2021

Methylation profiles of endometrioid and serous endometrial cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

7 January 2021

Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

7 January 2021

ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.96

7 January 2021